PMC:7795856 / 3738-4048 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"116","span":{"begin":290,"end":293},"obj":"Gene"},{"id":"125","span":{"begin":258,"end":266},"obj":"Species"},{"id":"137","span":{"begin":89,"end":95},"obj":"Disease"},{"id":"138","span":{"begin":249,"end":257},"obj":"Disease"}],"attributes":[{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Gene:134864"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"Tax:9606"},{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"MESH:D009369"},{"id":"A138","pred":"tao:has_database_id","subj":"138","obj":"MESH:D008545"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"which poorly respond to immune checkpoint inhibitors, into highly lymphocyte-infiltrated tumors and, thus, boosts therapeutic efficacy [15]. Indeed, a retrospective study evaluating clinical phase II data reported an increase in overall survival of melanoma patients receiving sequentially Tα1 and the immune c"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":249,"end":257},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002861"}],"text":"which poorly respond to immune checkpoint inhibitors, into highly lymphocyte-infiltrated tumors and, thus, boosts therapeutic efficacy [15]. Indeed, a retrospective study evaluating clinical phase II data reported an increase in overall survival of melanoma patients receiving sequentially Tα1 and the immune c"}